MEDI vs TRUF

MEDIDHarbor Health Care ETF (MEDI)

TRUFCVanEck Financials TruSector ETF

In short

MEDI Roughly 40 health care stocks, hand-picked across any size, from big pharma to small biotech. It's a concentrated stock-picker's book benchmarked to a growth health care index, not a hold-everything sector basket.

TRUF Most active funds exist to beat a benchmark. TRUF is active so it can hug one: it holds US financials at true market weight, sidestepping the diversification caps that force many sector funds to shrink their largest names.

Stated mandate

MEDI Seeks long-term growth of capital by primarily investing in common and preferred equity securities of companies of any market capitalization. Normally, at least 80% of net assets plus investment borrowings are invested in companies principally engaged in health care-related products and services.

TRUF The Fund is an actively managed ETF seeking long-term capital appreciation through securities of financials-related companies or instruments providing exposure to such companies.

Why people hold it

• MEDI About 40 names, not hundreds. Each pick has room to matter, which is the whole point of hiring an active manager instead of buying the entire sector.
• The mandate is explicit: at least 80% of assets in health care companies, any market cap, common or preferred shares. Big pharma and small biotech are both fair game.
• The yardstick is named up front, the Russell 3000 Growth Health Care Index, so the growth lean is disclosed rather than discovered later.

• TRUF A 0.10% expense ratio, against a 0.65% median for actively managed US equity funds in its peer group.
• The hybrid build (individual stocks plus targeted ETFs) keeps a sector's biggest contributors at uncapped weight while staying inside fund diversification rules.businesswire.comvaneck.com
• Roughly 80 names, measured against the MarketVector Top US Financials Companies Index. The mandate is the sector itself, not a stock picker's shortlist.

Worth knowing

• MEDI The 0.80% expense ratio sits above the median for actively managed US equity ETFs, so the stock picking carries a higher bar to clear.
• This is a small fund that doesn't trade heavily, which can mean wider bid-ask spreads than the giant sector index products.
• Payouts land once or twice a year, and a 40-stock growth portfolio reacts to single-name drug and trial news far more than a broad sector basket.

• TRUF VanEck says financials has not suffered the weighting distortions that hit tech and consumer discretionary, so the problem this structure solves is smaller here.vaneck.com
• Launched in 2026 and still a small fund, so spreads can run wider than in the sector's household-name ETFs. Limit orders are the usual tool for that.
• Owning other ETFs brings acquired fund fees, one of the items VanEck's expense arrangement does not cover, so total cost sits above the headline fee.vaneck.com

Full MEDI profile⁠

Full TRUF profile⁠